Health

Results: 457-468 of 6717

PR Newswire associated0

Large Independent Randomized Controlled Trial Validates MolecuLight's Transformative Impact on Wound Debridement, Showing Improved Outcomes and Lower Costs

European Commission Approves TEVIMBRA® as Neoadjuvant/Adjuvant NSCLC Treatment Ahead of Late-Breaking Data Presentation at WCLC 2025

PR Newswire associated0

Advancing DEL Technology for the Research Lab: HitGen Introduces OpenDEL™ 5.0

PR Newswire associated0

clock.bio Appoints Former BioNTech Executive Dr. Michael Boehler as Chief Business Officer

Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum

Oncoinvent ASA half-yearly report: Strong focus on financial discipline and advancing Phase 2 program in ovarian cancer

PR Newswire associated0

TheChallenge.org: New Study by Finds Reducing Phone Use is Over Twice as Hard as Enduring a Daily Ice Bath

PR Newswire associated0

AliveDx registers MosaiQ®, its Instrument for Multiplex Testing of Autoimmune Diseases, Allergies and Beyond, as a Class II Exempt Device with the U.S. Food and Drug Administration (FDA)

Debiopharm Pushes the Boundaries of Innovation in Antibiotic Development Against Gonorrhea with First-In-Human Debio 1453 Trial

BeOne to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

PR Newswire associated0

Piramal Pharma Publishes FY2025 Sustainability Report, Outlining Performance and Decarbonization Glidepath

PR Newswire associated0

High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient